Filing Details

Accession Number:
0001140361-14-022257
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-19 18:31:46
Reporting Period:
2014-05-16
Filing Date:
2014-05-19
Accepted Time:
2014-05-19 18:31:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1247681 Bryan V Lawlis C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-05-16 1,700 $56.87 9,700 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to a Rule 10b5-1 plan executed on December 9, 2013.
  2. The price in Column 4 is a weighted average price. The prices actually received ranged from $56.06 to $57.27. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.